Osteoporosis in orthopaedic trauma patients: A diagnosis and treatment protocol

Journal of Orthopaedic Trauma

Volumn 22, Issue 8, 2008, Pages 541-547

  Collinge, Cory ^a   Lebus, George ^b   Gardner, Michael J ^c   Gehrig, Laura ^d  

^a Harris Methodist Fort Worth Hospital   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Doctor's Hospital   (United States)

Author keywords

Fracture; High energy; Injury prevention; Osteoporosis; Protocol; Trauma

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; VITAMIN D;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FRACTURE; HEALTH STATUS; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL INJURY; OSTEOPOROSIS; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; TELECONSULTATION; ADOLESCENT; CALCANEUS; CLINICAL PROTOCOL; COHORT ANALYSIS; COMORBIDITY; ECHOGRAPHY; EMERGENCY HEALTH SERVICE; MIDDLE AGED; ORTHOPEDICS; PATIENT EDUCATION; PATIENT REFERRAL; PROSPECTIVE STUDY; RISK; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCANEUS; CLINICAL PROTOCOLS; COHORT STUDIES; COMORBIDITY; FEMALE; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; ORTHOPEDICS; OSTEOPOROSIS; PATIENT EDUCATION AS TOPIC; PREVALENCE; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RISK FACTORS; TEXAS; TRAUMA CENTERS;

EID: 56149105396     PISSN: 08905339     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOT.0b013e31817d9c99     Document Type: Article

References (69)

1. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17: 1726-1733.
2. Borgstrom F, Zethraeus N, Johnell O, et al. Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int. 2006;17:637-650.
3. Center JR, Bliuc D, Nguyen TV, et al. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA. 2007;297:387-394.
4. Dirschl DR, Henderson RC, Oakley WC. Accelerated bone mineral loss following a hip fracture:a prospective longitudinal study. Bone. 1997;21: 79-82.
5. Raisz LG. Clinical practice. Screening for osteoporosis. N Eng J Med. 2005;353:164-171.
6. Anonymous. American Academy of Orthopedic Surgeons Web site. Available at: http://orthoinfo.aaos.org/topic.cfm?topic=A00232. Accessed 12/07.
7. Anonymous. National Osteoporosis Foundation Clinical Practice Guideline. Available at:http://www.nof.org/professionals/Clinicians-Guide.htm. Accessed 12/07.
8. Andrade SE, Majumdar SR, Chan KA, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med. 2003;163:2052-2057.
9. Gardner MJ, Flik KR, Mooar P, et al. Improvement in the undertreatment of osteoporosis following hip fracture. J Bone Joint Surg Am. 2002;84-A: 1342-1348.
10. Fisher AA, Davis MW, Smith PN. Undertreatment of osteoporosis following hip fracture. J Bone Joint Surg Am. 2003;85-A:1394-1395.
11. Feldstein AC, Nichols GA, Elmer PJ, et al. Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am. 2003;85-A:2294- 2302.
12. Kanis JA, Johnell O, Oden A, et al. Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone. 2000;27:585-590.
13. Collinge C, Gehrig L. Quantitative ultrasound of the calcaneus in orthopedic trauma patients. In: Proceedings of the 7th International Symposium on Osteoporosis:Translating Research into Clinical Practice. Washington, DC; April 18-22, 2007. Abstract.
14. Lochmuller EM, Muller R, Kuhn V, et al. Can novel clinical densitometric techniques replace or improve DXA in predicting bone strength in osteoporosis at the hip and other skeletal sites? J Bone Miner Res. 2003; 18:906-912.
15. Bauer DC, Gluer CC, Cauley JA, et al. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1997;157:629-634.
16. Hans D, Dargent-Molina P, Schott AM, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women:the EPIDOS prospective study. Lancet. 1996;348:511-514.
17. Pluijm SM, Graafmans WC, Bouter LM, et al. Ultrasound measurements for the prediction of osteoporotic fractures in elderly people. Osteoporos Int. 1999;9:550-556.
18. Khaw KT, Reeve J, Luben R, et al. Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study. Lancet. 2004;363: 197-202.
19. Frost ML, Blake GM, Fogelman I. A comparison of fracture discrimination using calcaneal quantitative ultrasound and dual X-ray absorptiometry in women with a history of fracture at sites other than the spine and hip. Calcif Tissue Int. 2002;71:207-211.
20. Huopio J, Kroger H, Honkanen R, et al. Calcaneal ultrasound predicts early menopausal fractures as well as axial BMD. A prospective study of 422 women. Osteoporos Int. 2004;15:190-195.
21. Lewiecki EM, Richmond B, Miller PD. Uses and misuses of quantitative ultrasonography in managing osteoporosis. Cleve Clin J Med. 2006;73: 742-746,749-752.
22. Durosier C, Hans D, Krieg MA, et al. Prediction and demonstration of osteoporotic hip fracture in postmenopausal women. J Clin Densitom. 2006;9:475-495.
23. Thompson PW, Taylor J, Oliver R, et al. Quantitative ultrasound (QUS) of the heel predicts wrist and osteoporosis-related fractures in women age 45-75 years. J Clin Densitom. 1998;1:219-225.
24. Lochmuller EM, Zeller JB, Kaiser D, et al. Correlation of femoral and lumbar DXA and calcaneal ultrasound, measured in situ with intact soft tissues, with the in vitro failure loads of the proximal femur. Osteoporos Int. 1998;8:591-598.
25. Varenna M, Sinigaglia L, Adami S, et al. Association of quantitative heel ultrasound with history of osteoporotic fractures in elderly men:the ESOPO study. Osteoporos Int. 2005;16:1749- 1754.
26. Papapoulos SE, Quandt SA, Liberman UA, et al. Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in post-menopausal women. Osteoporos Int. 2005;16:468-474.
27. Doetsch AM, Faber J, Lynnerup N, et al. The effect of calcium and vitamin D3 supplementation on the healing of the proximal humerus fracture: a randomized placebo-controlled study. Calcif Tissue Int. 2004;75: 183-188.
28. Papadimitropoulos E, Wells G, Shea B, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VIII:meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev. 2002;23:560-569.
29. Gardner MJ, Brophy RH, Demetrakopoulos D, et al. Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized trial. J Bone Joint Surg Am. 2005;87:3-7.
30. Chapuy MC, Meunier PJ. Prevention of secondary hyperparathyroidism and hip fracture in elderly women with calcium and vitamin D3 supplements. Osteoporos Int. 1996;6 (suppl 3):60-63.
31. Dawson-Hughes B. Calcium plus vitamin D and the risk of fractures. N Engl J Med. 2006;354:2285-2287.
32. Cuddihy MT, Gabriel SE, Crowson CS, et al. Osteoporosis intervention following distal forearm fractures:a missed opportunity? Arch Intern Med. 2002;162:421-426.
33. Cuddihy MT, Amadio PC, Gabriel SE, et al. A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture. Osteoporos Int. 2004;15:695-700.
34. Ashe M, Khan K, Guy P, et al. Wristwatch-distal radial fracture as a marker for osteoporosis investigation:a controlled trial of patient education and a physician alerting system. J Hand Ther. 2004;17: 324-328.
35. Ashe MC, McKay HA, Janssen P, et al. Improving osteoporosis management in at-risk fracture clinic patients. J Am Geriatr Soc. 2005;53: 727-728.
36. Edwards BJ, Iris M, Ferkel E, et al. Postmenopausal women with minimal trauma fractures are unapprised of the existence of low bone mass or osteoporosis. Maturitas. 2006;53:260-266.
37. Simonelli C, Chen YT, Morancey J, et al. Evaluation and management of osteoporosis following hospitalization for low-impact fracture. J Gen Intern Med. 2003;18:17-22.
38. Bogoch ER, Elliot-Gibson V, Beaton DE, et al. Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am. 2006;88: 25-34.
39. Kern LM, Powe NR, Levine MA, et al. Association between screening for osteoporosis and the incidence of hip fracture. Ann Intern Med. 2005;142: 173-181.
40. Sanders KM, Pasco JA, Ugoni AM, et al. The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community:the Geelong Osteoporosis Study. J Bone Miner Res. 1998; 13:1337-1342.
41. Tornetta P3rd, Hirsch EF, Howard R, et al. Skeletal injury patterns in older females. Clin Orthop Relat Res. 2004;(422):55-56.
42. Marcus R, Wong M, Heath H, et al. Antiresorptive treatment of postmenopausal osteoporosis:comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocr Rev. 2002;23: 16-37.
43. Malavolta N, Mule R, Frigato M. Quantitative ultrasound assessment of bone. Aging Clin Exp Res. 2004;16 (suppl 3):23-28.
44. Anonymous. International Society for Clinical Densitometry, Inc. Official Position Statement 2005. Available at: http://iscd.org/Visitors/positions/ OP-Index.cfm. Accessed 1/07.
45. Hans D, Downs RW Jr, Duboeuf F, et al. Skeletal sites for osteoporosis diagnosis:the 2005 ISCD Official Positions. J Clin Densitom. 2006;9: 15-21.
46. Burke PK. Use of ultrasound to screen for osteoporosis:comparison with spine and femur DXA. In: Proceedings of the American Society for Bone and Mineral Research Annual Meeting. Minneapolis, MN; September 19-23, 2003.
47. Hans D, Hartl F, Krieg MA. Device-specific weighted T-score for two quantitative ultrasounds:operational propositions for the management of osteoporosis for 65 years and older women in Switzerland. Osteoporos Int. 2003;14:251-258.
48. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures:results from the Fracture Intervention Trial. JAMA. 1998;280: 2077-2082.
49. Stewart A, Felsenberg D, Eastell R, et al. Relationship between risk factors and QUS in a European population:the OPUS study. Bone. 2006;39: 609-615.
50. Ross PD. Osteoporosis. Frequency, consequences, and risk factors. Arch Intern Med. 1996;156:1399-1411.
51. Anastasopoulou C, Rude RK. Bone mineral density screening:assessment of influence on prevention and treatment of osteoporosis. Endocr Pract. 2002;8:199-201.
52. Diaz-Guerra GM, Gil-Fraguas L, Jodar E, et al. Quantitative ultrasound of the calcaneus in long-term liver or cardiac transplantation patients. J Clin Densitom. 2006;9;469-474.
53. Formiga F, Rivera A, Nolla JM, et al. Failure to treat osteoporosis and the risk of subsequent fractures in elderly patients with previous hip fracture: a five-year retrospective study. Aging Clin Exp Res. 2005;17:96-99.
54. Elliot-Gibson V, Bogoch ER, Jamal SA, et al. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int. 2004;15:767-778.
55. Mauck KF, Cuddihy MT, Atkinson EJ, et al. Use of clinical prediction rules in detecting osteoporosis in a population-based sample of postmenopausal women. Arch Intern Med. 2005;165:530-536.
56. Kaufman JD, Bolander ME, Bunta AD, et al. Barriers and solutions to osteoporosis care in patients with a hip fracture. J Bone Joint Surg Am. 2003;85-A:1837-1843.
57. Bliuc D, Ong CR, Eisman JA, et al. Barriers to effective management of osteoporosis in moderate and minimal trauma fractures:a prospective study. Osteoporos Int. 2005;16:977-982.
58. Skedros JG, Holyoak JD, Pitts TC. Knowledge and opinions of orthopaedic surgeons concerning medical evaluation and treatment of patients with osteoporotic fracture. J Bone Joint Surg Am. 2006;88:18-24.
59. Sidwell AI, Wilkinson TJ, Hangar HC. Secondary prevention of fractures in older people:evaluation of a protocol for the investigation and treatment of osteoporosis. Intern Med J. 2004;34:129-132.
60. Bellantonio S, Fortinsky R, Prestwood K. How well are community-living women treated for osteoporosis after hip fracture? J Am Geriatr Soc. 2001; 49:1197-1204.
61. Meunier PJ, Arlot M, Chavassieux P, Yates AJ. The effects of alendronate on bone turnover and bone quality. Int J Clin Pract Suppl. 1999;101: 14-17.
62. Hodgson SF, Watts NB, Bilezikian JP, et al. American Association for Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis:2001 edition, with selected updates for 2003. Endocr Pract. 2003;9: 544-564.
63. Kanis JA, Johnell O, Black DM, et al. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis:a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial. Bone. 2003;33:293-300.
64. Cree MW, Juby AG, Carriere KC. Mortality and morbidity associated with osteoporosis drug treatment following hip fracture. Osteoporos Int. 2003; 14:722-727.
65. Harrington JT, Barash HL, Day S, et al. Redesigning the care of fragility fracture patients to improve osteoporosis management:a healthcare improvement project. Arthritis Rheum. 2005;53:198-204.
66. Jones G, Warr S, Francis E, et al. The effect of a fracture protocol on hospital prescriptions after minimal trauma fractured neck of the femur: a retrospective audit. Osteoporos Int. 2005;16:1277-1280.
67. Harrington JT, Deal CL. Successes and failures in improving osteoporosis care after fragility fracture:results of a multiple-site clinical improvement project. Arthritis Rheum. 2006;55:724-728.
68. Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medications. Arch Intern Med. 2005;165:2414-2419.
69. Yood RA, Emani S, Reed JI, et al. Compliance with pharmacological therapy for osteoporosis. Osteoporos Int. 2003;14:965-968.